by Antonio Regalado from MIT Technology Review on (#6R0BY)
In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it's been common for lawyers to try to overturn patents held by competitors by pointing out errors or inconsistencies. But now, in a surprise twist, the team that earned the Nobel Prize in chemistry for developing CRISPR is asking to cancel two of...